Metraipolis › archive › dc_35443dbf8b8b
Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies — Europe PMC PMID:31730655
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/31730655
- DOI
- 10.1371/journal.pgen.1008490
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-10T02:08:27.519Z
- SHA-256 of the archived text
82032af382f78ebf012ed13b2e58983858046b428c3121ccae4e0412bc789ef3- Stable URL of this page
https://metraipolis.com/documento/dc_35443dbf8b8b
How to cite
Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies — Europe PMC PMID:31730655 — Europe PMC (en), https://europepmc.org/article/MED/31730655 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_35443dbf8b8b (Metraipolis archive dc_35443dbf8b8b, sha256 82032af382f78ebf012ed13b2e58983858046b428c3121ccae4e0412bc789ef3)
BibTeX
@misc{dc35443dbf8b8b,
title = {Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies — Europe PMC PMID:31730655},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/31730655},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_35443dbf8b8b; sha256 82032af382f78ebf012ed13b2e58983858046b428c3121ccae4e0412bc789ef3},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31730655. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Despite genetics being accepted as the primary cause of familial aggregation for most diseases, it is still unclear whether afflicted families are likely to share a single highly penetrant rare variant, many minimally penetrant common variants, or a combination of the two types of variants. We therefore use recent estimates of SNP heritability and the liability threshold model to estimate the proportion of afflicted families likely to carry a rare, causal variant. We then show that Polygenic Risk Scores (PRS) may be useful for identifying families likely to carry such a rare variant and therefore for prioritizing families to include in sequencing studies with that aim. Specifically, we introduce a new statistic that estimates the proportion of individuals carrying causal rare variants based on the family structure, disease pattern, and PRS of genotyped individuals. Finally, we consider data from the MelaNostrum consortium and show that, despite an estimated PRS heritability of only 0.05 for melanoma, families carrying putative causal variants had a statistically significantly lower PRS, supporting the idea that PRS prioritization may be a useful future tool. However, it will be important to evaluate whether the presence of rare mendelian variants are generally associated with the proposed test statistic or lower PRS in future and larger studies. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS genetics, 2019 (prima pubblicazione 2019-11-15). Identificativi: PMID 31730655 · PMCID PMC6881075 · DOI 10.1371/journal.pgen.1008490. Descrittori MeSH principali: Genetic Predisposition to Disease; Sequence Analysis, DNA. Pagina: https://europepmc.org/article/MED/31730655 — https://doi.org/10.1371/journal.pgen.1008490. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-10T02:05:31.466Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.